# Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients

> **NCT07303296** · PHASE2 · RECRUITING · sponsor: **GenSight Biologics** · enrollment: 14 (estimated)

## Conditions studied

- Leber Hereditary Optic Disease

## Interventions

- **GENETIC:** GS010 High dose
- **GENETIC:** GS010 Low dose

## Key facts

- **NCT ID:** NCT07303296
- **Lead sponsor:** GenSight Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-22
- **Primary completion:** 2028-05-15
- **Final completion:** 2028-06
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07303296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07303296, "Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07303296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*